http://www.fda.gov/cder/orange/appendix_a.txt SODIUM, AMINOSALICYLATE SODIUM PACERONE, AMIODARONE HYDROCHLORIDE PACLITAXEL, PACLITAXEL PAGITANE, CYCRIMINE HYDROCHLORIDE PAMELOR, NORTRIPTYLINE HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PAMINE FORTE, METHSCOPOLAMINE BROMIDE PAMINE, METHSCOPOLAMINE BROMIDE PANCURONIUM BROMIDE, PANCURONIUM BROMIDE PANCURONIUM, PANCURONIUM BROMIDE PANDEL, HYDROCORTISONE PROBUTATE...
DDPA November 1995 20-469 BECLOMETHASONE SCHERING BECLOMETHASONE DIPROPIONATE 09-NOV-95 DIPROPIONATE KENILWORTH, NJ MONOHYDRATE MONOHYDRATE 07033 EQ 0.084MG DIPROP/INH (SPRAY, METERED) (STEROID) 20-539 LAMISIL SANDOZ TERBINAFINE HYDROCHLORIDE 21-NOV-95 (TABLET) EAST HANOVER, NJ EQ 250MG BASE 07936 (ANTIFUNGAL) 20-291 COMBIVENT BOEHRINGER INGELHEIM ALBUTEROL SULFATE 22-NOV-95 (AEROSOL, METERED)...
http://www.fda.gov/cder/da/ddpa92.wpd 50 671 VANCOCIN HCL LILLY VANCOMYCIN HYDROCHLORIDE 03 24 92 IN PLASTIC CONTAINER INDIANAPOLIS, IN EQ 500MG BASE/100ML (INJECTABLE) 46285 (ANTIBIOTIC, GLYCOPEPTIDE) 19 830 LIDOCAINE HCL MCGAW LIDOCAINE HYDROCHLORIDE 03 26 92 IN DEXTROSE 5% IN IRVINE, CA 200MG/100ML PLASTIC CONTAINER 92713 400MG/100ML (INJECTABLE) 800MG/100ML (ANTIARRHYTHMIC) 19 881 BUTOCONAZOLE NITRATE SYNTEX...
FDA Drug Approvals List- January 1998 45 Dosage Form: INJECTABLE Applicant: NOVARTIS PHARMACEUTICALS CORP Active Ingredient(s): DIHYDROERGOTAMINE MESYLATE OTC/RX Status: RX Application #: 020560 Labeling Supplement#: 010 To Original New Drug Application Approval Date: 27-JAN-98 Trade Name: FOSAMAX Dosage Form: TABLET Applicant: MERCK RESEARCH LABORATORIES Active Ingredient(s): ALENDRONATE SODIUM OTC/RX Status: RX...
DDPA August 1996 74-635 NAPROXEN SODIUM NOVOPHARM NAPROXEN SODIUM 20-AUG-96 (TABLET) SCARBOROUGH, ONTARIO 220MG CANADA (NONSTEROIDAL ANTI-INFLAMMATORY) 74-570 ACYCLOVIR ROXANE LABS ACYCLOVIR 30-AUG-96 (CAPSULE) COLUMBUS, OH 200MG 43216 (ANTIVIRAL) ***LABELING SUPPLEMENTS TO ORIGINAL NDAs*** 08-678 ISONIAZID EON MANUFACTURE LABS ISONIAZID 01-AUG-96 (TABLET) LAURELTON, NY 100MG 11413 300MG (LABELING...
DDPA June 1996 74-515 TIMOLOL MALEATE AKRON TIMOLOL MALEATE 17-JUN-96 (SOLUTION) DECATUR, IL EQ 0.25% BASE 62525 (BETA ADRENERGIC BLOCKER) 74-516 TIMOLOL MALEATE AKRON TIMOLOL MALEATE 17-JUN-96 (SOLUTION) DECATUR, IL EQ 0.5% BASE 62525 (BETA ADRENERGIC BLOCKER) 16-096 MINTEZOL MSD THIABENDAZOLE 03-JUN-96 (TABLET, CHEWABLE) WEST POINT, PA 500MG 19486 (LABELING REVISION -- INDICATIONS AND USAGE;...
Drug Approvals December 1996 Drug Approvals for December 1996 Definitions and Notes December 1996 Original New Drug Applications Original Application #: 020681 Approval Date: 31-DEC-96 Trade Name: ORTHO TRI-CYCLEN Chemical Type: 6 Therapeutic Potential: S Dosage Form: TABLET Applicant: RW JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE DIV ORTHO PHARMACEUTICAL CORP Active Ingredient(s): ETHINYL ESTRADIOL; NORGESTIMATE...
Drug Approvals September 1996 CATARRHALIS TO THE INDICATIONS AND USAGE SECTION Approvable Original New Drug Applications Original Application #: 020535 Approvable Date: 30-SEP-96 Trade Name: DURACT Dosage Form: CAPSULE Applicant: WYETH AYERST LABORATORIES INC Active Ingredient(s): BROMFENAC SODIUM OTC/RX Status: RX Original Application #: 020690 Approvable Date: 19-SEP-96 Trade Name: ARICEPT Dosage Form: TABLET...
August Drug Approvals Original Application #: 020508 Approval Date: 29-AUG-96 Trade Name: LAC-HYDRIN Chemical Type: 3 Therapeutic Potential: S Dosage Form: CREAM Applicant: BRISTOL MYERS CO Active Ingredient(s): AMMONIUM LACTATE OTC/RX Status: RX Indication(s): ICHTHYOSIS VULGARIS AND XEROSIS Original Application #: 020532 Approval Date: 26-AUG-96 Trade Name: IVY BLOCK Chemical Type: 1 Therapeutic...
